Complications of cancer
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Complications of Cancer: A Comprehensive Overview
Cancer and its treatments can lead to a wide array of complications, significantly impacting patient outcomes and quality of life. This article synthesizes current research on the various complications associated with cancer, focusing on infectious, cardiovascular, neurologic, pulmonary, and treatment-related issues.
Infectious Complications in Cancer Patients
Cancer patients are particularly susceptible to infections due to several factors, including immunosuppression from the malignancy itself, tumor-directed therapies, and breaches in mucosal or skin barriers. Neutropenia is a critical risk factor, making patients vulnerable to infections in the bloodstream, lungs, gastrointestinal tract, central nervous system, urinary tract, and skin. Pneumonias are notably the leading cause of infection in cancer patients admitted to intensive care units (ICUs).
Cardiovascular Complications of Cancer Therapy
Cancer treatments, including chemotherapy, radiotherapy, and surgery, can lead to significant cardiovascular complications. These include heart failure, myocardial ischemia/infarction, hypertension, thromboembolism, and arrhythmias. The cardiotoxicity of chemotherapeutic agents is a major concern, as it can severely impact the prognosis and survival of cancer patients. The aging population and the introduction of new cancer therapies are likely to increase the prevalence of these complications .
Neurologic Complications in Cancer Patients
Neurologic symptoms are common and challenging to diagnose in cancer patients. These symptoms can result from direct effects of malignant lesions, systemic complications, paraneoplastic disorders, or side effects of cancer treatments. Early diagnosis and treatment are crucial for improving quality of life and long-term outcomes. Acute neurologic complications often require hospital admission and can include encephalopathy, cerebellar alterations, disturbed consciousness, or seizures.
Pulmonary Complications of Cancer Treatment
Pulmonary complications are frequently observed in cancer patients, particularly those undergoing treatment for lung cancer. These complications can be difficult to distinguish from disease-related symptoms. Common issues include interstitial pneumonitis, respiratory distress, and infections. In childhood cancer survivors, pulmonary complications can lead to long-term morbidity and mortality, necessitating regular screening and early intervention .
Treatment-Related Complications
Modern cancer therapies, including targeted and immunotherapies, have introduced new toxicity profiles. Severe complications such as cytokine-release syndrome (CRS), immune-related adverse events (IRAEs), and central nervous system toxicities are increasingly recognized. CRS, characterized by fever, hypotension, and skin reactions, is a significant concern in patients receiving monoclonal antibodies or CAR T-cell therapies. IRAEs can affect various organs, leading to colitis, diarrhea, and endocrine disorders, often requiring ICU admission.
Outcomes in Critically Ill Cancer Patients
Cancer-related complications often necessitate ICU admission, with high rates of mortality. Common complications include chemotherapy/radiation-induced toxicity, venous thromboembolism, respiratory failure, gastrointestinal involvement, and vena cava syndrome. These complications are associated with worse performance status and higher mortality rates, underscoring the need for vigilant management and early intervention.
Conclusion
Cancer and its treatments pose significant risks for a variety of complications, affecting multiple organ systems. Understanding these complications and their management is crucial for improving patient outcomes and quality of life. Ongoing research and clinical vigilance are essential to mitigate these risks and provide comprehensive care for cancer patients.
Sources and full results
Most relevant research papers on this topic